Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2022-12-14 Remuneration Information
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Exercise period extension - existing share options
Remuneration Information Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a date (14 December 2022) and company information, typical of a regulatory news service announcement from the London Stock Exchange. The content specifically details an 'amendment to the exercise period for certain options' granted to a Director/PDMR (Dr Alexandre Akoulitchev) and includes a mandatory notification table compliant with UK Market Abuse Regulation regarding insider transactions (extension of option expiry). This type of filing, concerning personal share transactions by directors, directly maps to the 'Director's Dealing' category (DIRS). It is not a full financial report (10-K, IR), an earnings release (ER), or a general announcement (RNS), as it concerns a specific insider transaction event.
2022-12-14 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 3114I' and contains the standard formatting for notifications distributed via RNS (Regulatory News Service) of the London Stock Exchange. The content is a 'TR-1: Standard form for notification of major holdings', which details a change in share ownership crossing a notification threshold (from 4.91% to 5.00%). This type of filing, reporting changes in significant shareholdings, directly corresponds to the Major Shareholding Notification category. Although RNS is mentioned, the specific content is a Major Shareholding Notification, making 'MRQ' the most precise classification over the general 'RNS' fallback. The document length (4867 chars) is substantial enough to be the report itself, not just an announcement of a report.
2022-12-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6917H' and concludes with boilerplate text stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing a change in voting rights held by a shareholder (The Chancellor, Masters and Scholars of the University of Oxford). This type of mandatory disclosure regarding significant changes in share ownership thresholds falls directly under the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a notification of a change in major shareholding, making MRQ the most precise classification.
2022-11-28 English
Discussion about EpiSwitch CiRT at Key Summit
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 0351H' and contains an announcement dated '21 November 2022' regarding a company event participation and product discussion ('Prominent oncologist to discuss advantages of Oxford BioDynamics' EpiSwitch CiRT at the 2022 Liquid Biopsy Virtual Summit'). The text concludes with a disclaimer stating, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS... Reach announcements are identified with an orange label...'. This structure strongly indicates a general press release or regulatory news service announcement that is explicitly non-regulatory in nature, but distributed via the RNS system. Since it is an announcement about an upcoming event and product promotion, and not a formal financial report (like 10-K, IR, ER) or a specific corporate action filing (like DIV, SHA, DIRS), the most appropriate classification is the general regulatory/news fallback category, RNS, as it is distributed through that channel and is not a core financial filing type. The document length (8236 chars) is substantial enough that it is not just a brief 'Report Publication Announcement' (RPA) which typically just points to another document.
2022-11-21 English
Second Price Monitoring Extn
Transaction in Own Shares Classification · 99% confidence The document is very short (1940 characters) and contains the header 'RNS Number : 9660G' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement made via the regulatory news service. Since it is a specific regulatory announcement that doesn't fit into the defined categories like DIV, DIRS, or ER, and it is clearly an RNS distribution, the most appropriate classification is the general regulatory filing category, RNS, as it is a direct regulatory news service update.
2022-11-18 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a short, specific operational update rather than a comprehensive financial report (like 10-K or IR) or a standard earnings release (ER). Given its nature as a general regulatory announcement disseminated via the RNS system, and its brevity (1923 chars), it fits best under the general regulatory announcement category.
2022-11-18 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.